Le Lézard
Classified in: Business
Subject: DIVIDENDS

Alaris Royalty Corp. Declares May Dividend


CALGARY, ALBERTA--(Marketwired - May 18, 2017) -

NOT FOR DISTRIBUTION IN THE UNITED STATES. 

FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW.

Alaris Royalty Corp. ("Alaris" or the "Corporation") (TSX:AD) announces that the Board of Directors of the Corporation has declared a dividend of $0.135 per common share for the month of May 2017, representing $1.62 per share on an annualized basis. The dividend is payable on June 15, 2017 to shareholders of record on May 31, 2017. The ex-dividend date is May 29, 2017.

This dividend is designated by the Corporation to be an eligible dividend for the purpose of the Income Tax Act (Canada) and any similar provincial or territorial legislation. An enhanced dividend tax credit applies to eligible dividends paid to Canadian residents.

About Alaris:

The Corporation provides alternative financing for a diversified group of private businesses ("Private Company Partners") in exchange for royalties or distributions from the Private Company Partners, with the principal objective of generating stable and predictable cash flows for dividend payments to its shareholders. Distributions from the Private Company Partners are adjusted each year based on the percentage change of a "top line" financial performance measure such as gross margin and same-store sales and rank in priority to the owners' common equity position.


These press releases may also interest you

at 21:05
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...

at 21:01
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 21:00
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful...

at 20:55
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...

at 20:50
Pomerantz LLP is investigating claims on behalf of investors of Jabil Inc. ("Jabil" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 20:40
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....



News published on and distributed by: